Frontlight ResearchEarly access
Trial site
Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Coronary artery disease2 trials
- Phase
- Phase 42 trials
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Amgen1 trial
- Beijing Shijitan Hospital, Capital Medical University1 trial
- Beijing Tiantan Hospital1 trial
- Dr. Willmar Schwabe GmbH & Co. KG1 trial
- Harbin Medical University1 trial
Running trials
Recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026